Showing results (191-200 of 228) with videos related to
Sort By:
Pageof 23
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2016
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCRDaniel J Munson, Colt A Egelston, Kami E Chiotti, et al.Cancer Cell|April 2, 2019
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic TargetsLuca Cassetta, Stamatina Fragkogianni, Andrew H Sims, et al.Nature Communications|September 21, 2018
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancerTyler Risom, Ellen M Langer, Margaret P Chapman, et al.Breast Cancer Research : BCR|July 3, 2016
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancerZhi Hu, Jian-Hua Mao, Christina Curtis, et al.Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.Nature Communications|June 10, 2018
Gene flow contributes to diversification of the major fungal pathogen Candida albicansJeanne Ropars, Corinne Maufrais, Dorothée Diogo, et al.Cancer Cell|December 13, 2006
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesRichard M Neve, Koei Chin, Jane Fridlyand, et al.NPJ Precision Oncology|October 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.Proceedings of the National Academy of Sciences of the United States of America|August 20, 2015
Phylogenetic analyses of melanoma reveal complex patterns of metastatic disseminationJ Zachary Sanborn, Jongsuk Chung, Elizabeth Purdom, et al.Cancer Cell|November 6, 2020
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell LinesWei Zhao, Jun Li, Mei-Ju M Chen, et al.Pageof 23